Latest AI and machine learning research in alzheimer's disease for healthcare professionals.
Amyloid fibrils formed by the misfolding and aggregation of proteins are a pathological hallmark of many neurodegenerative conditions including Alzheimer's disease (AD). Although recent studies have shown that pre-fibrillar species including low molecular-weight oligomers are more toxic in vitro than mature fibrils, and correlate better with cognitive decline in AD patients, techniques to study th...
Alzheimer's disease (AD) is a progressive neurodegenerative disorder that remains a global challenge due to its complex pathology and the lack of definitive diagnostic tools. This paper introduces an innovative approach to predicting and analyzing Alzheimer's disease by constructing signed brain network models and leveraging signed graph neural network technologies. By modeling the brain network a...
Vascular Cognitive Impairment and Dementia (VCID), the second most common form of dementia, is becoming increasingly prevalent worldwide. However, cur...
INTRODUCTION: Systemic inflammation has been identified as a key factor in neurodegeneration but the value of circulating inflammatory proteins in dem...
Neurodegenerative diseases (NDDs), including Alzheimer's disease (AD) and Parkinson's disease (PD), are major public health challenges lacking effecti...
Due to the late manifestation of structural symptoms and symptomatic overlap, neurodegenerative diseases such as Parkinson's Disease (PD) and Alzheime...
OBJECTIVES: Given the heterogeneous nature of Alzheimer's Disease (AD) and its higher prevalence in females, it is crucial to understand sex-related d...
For patients with serious illnesses, goals of care conversations improve quality of life and patient and family satisfaction and may reduce healthcare...
Convolutional neural networks (CNNs) are widely recognized for their high precision in image classification. Nevertheless, the lack of transparency in...
OBJECTIVES: This study aims to develop a deep learning model to assist physicians in accurately classifying negative, equivocal, and positive β-amyloi...
UNLABELLED: Alzheimer’s disease (AD) is a neurodegenerative disorder that progressively deteriorates a person’s memory, as well as their ability to th...
BACKGROUND: In recent years, the incidence of cognitive diseases has also risen with the significant increase in population aging. Among these disease...
BACKGROUND: Dementia and Parkinson's disease (PD) are among the most prevalent neurological disorders globally. Most previous research has focused on ...
BACKGROUND: Alzheimer's disease (AD) is a prevalent neurodegenerative disorder. This study aims to identify biomarkers associated with glutamine metab...
BACKGROUND: Disrupted sleep and circadian rhythms in dementia affect rest-activity patterns and impact quality of life, safety, and caregiver burden. ...
BACKGROUND: Advances in artificial intelligence (AI) have revolutionized digital wellness by providing innovative solutions for health, social connect...
BACKGROUND: The complex brain changes involved in Alzheimer's disease (AD) development constitute a high-dimensional nonlinear feature space where dee...
Vascular dementia (VaD) is the second most common type of dementia, yet its pathogenesis is not fully understood, and effective diagnostic and therape...
Brain imaging genetics aims to uncover the pathological mechanisms and improve the diagnosis of brain diseases, particularly neurodegenerative disorde...
PURPOSE: There has been significant progress in detecting Alzheimer's disease (AD) using retinal imaging. We developed an ensemble learning-based deep...